HOME >> MEDICINE >> NEWS
ILEX Oncology & LeukoSite report results from pivotal Phase II CAMPATH (R) trial; Results suggest new hope for refractory chronic lymphocytic leukemia

Results suggest new hope for patients with refractory chronic lymphocytic leukemia Data to support BLA submission

BARCELONA, SPAIN, June 12 ---ILEXTM Oncology, Inc. (NASDAQ: ILXO) and LeukoSite, Inc. (NASDAQ: LKST) today announced final results from an international, multi-center, pivotal Phase II clinical trial of CAMPATHR for the treatment of patients with B-cell chronic lymphocytic leukemia (CLL) who are refractory to fludarabine. Results of the trial were presented this weekend at the 4th Congress of the European Haematology Association (EHA) by Michael J. Keating, MB, BS, of the M.D. Anderson Cancer Center, one of the trial's principal investigators and an internationally recognized expert in CLL. The companies plan to submit a Biologics License Application (BLA) based largely on these results later this year.

"The results of this trial are encouraging," said Dr. Keating, Associate Head for Clinical Research and Professor of Medicine and internist for the Department of Leukemia at M.D. Anderson Cancer Center. "The data suggest that CAMPATH may provide an important new treatment option for fludarabine-refractory patients, a group for whom the prognosis has, to date, been extremely poor. While the treatment of patients with leukemia has relied on chemotherapeutic agents, the use of monoclonal antibodies is an innovative approach to circumventing the disease's mechanisms for resistance."

The non-comparative trial, involved 93 previously treated patients who had received prior alkylating agents and failed fludarabine therapy (median of three prior treatment regimens). For these patients, the median life expectancy is usually six to nine months.

In the trial, patients participating at the 20 clinical sites in the United States and Europe received 30 mg of CAMPATH on an outpatient basis, as an intravenous infusion, three times a week, for four to 12 weeks. The dose was gradually escalated over the first week to 30 mg, in or
'"/>

Contact: Deborah Sibley, ILEX Oncology
210-949-8287
Porter Novelli
12-Jun-1999


Page: 1 2 3 4 5

Related medicine news :

1. The 23rd Congress of the European Society for Therapeutic Radiology and Oncology (ESTRO)
2. Oncology Nursing Society honors Fox Chase Cancer Center nurse with Radiation Therapy Nursing Award
3. The Lancet Oncology (TLO)
4. The Lancet Oncology press release
5. The Lancet Oncology (TLO) and the Lancet Infectious Diseases (TLID)
6. The Lancet Oncology (TLO) June 2002
7. The Lancet Oncology (TLO) and The Lancet Infectious Diseases (TLID)
8. The Lancet Oncology and The Lancet Infectious Diseases
9. V. Craig Jordan Will Present Results Of Raloxifene Breast Cancer Study At American Society For Clinical Oncology Meeting
10. First UK cases of previously rare disease reported in gay men
11. Health care report cards may increase racial/ethnic disparities in bypass operations

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2020)... ... March 27, 2020 , ... With social distancing, or more ... the day, people of all ages are challenged to find different ways to ... in the best of times—the physical distance mandated to prevent the pandemic’s spread ...
(Date:3/28/2020)... ... , ... iPatientCare, a pioneer in cloud-based ambulatory EHR ... expanded the availability of telehealth services and other initiatives to help clients amid ... big role in fighting coronavirus . Increasing the telehealth services across the nation ...
(Date:3/27/2020)... ... March 27, 2020 , ... NeoTract, a wholly owned subsidiary ... urology, today announced that Harpreet Wadhwa, M.D., East Valley Urology Center in Mesa, ... that Dr. Wadhwa has achieved a high level of training and experience with ...
(Date:3/22/2020)... ... March 21, 2020 , ... TriageLogic, a leader ... medical organizations, and health centers can use for patient care during the COVID-19 ... medical professionals are working around the clock to implement emergency support solutions for ...
(Date:3/20/2020)... DALLAS (PRWEB) , ... March 20, 2020 , ... ... for their medical clinics. The virtual waiting room lets patients present online, complete ... place in the queue, wait for their turn, and get signaled that their clean ...
Breaking Medicine News(10 mins):
(Date:3/22/2020)... ... March 21, 2020 , ... ... Temple University Hospital (TUH), its Department of Thoracic Medicine and Surgery, and the ... using HGE Health’s COVID Care symptom tracking platform and triage/care coordination services. Temple ...
(Date:3/20/2020)... ... March 20, 2020 , ... ... of companies with its US headquarters in New Jersey, recently launched a new ... organizations affected and present in the local communities across New Jersey, Maryland and ...
(Date:3/20/2020)... ... March 20, 2020 , ... Users who have tested positive for ... a crowd-sourced database of detailed location information, such as a specific building on campus ... or exposure to the virus. The app will also help people to more easily ...
Breaking Medicine Technology:
Cached News: